Michael Choy joined Boston Consulting Group in 2005 and has worked in the New Jersey, San Francisco, and Shanghai offices. He is a leader in BCG's work in the US on COVID-19 crisis response and vaccine development and deployment; and is also one of the firm’s experts in cell and gene therapy, defining strategies and operations for new therapeutic modalities.

Michael has extensive experience serving industry-leading clients in the US, Europe, and Asia on high-impact programs, developing strategies, delivering innovative solutions, leading large teams, guiding executive decision-making, and driving client relationships. He has worked with clients on R&D, manufacturing, and commercialization of new medicines; large-scale change and PMI; R&D governance, organization, and operations; population health and disease surveillance; market access and commercialization; and global health.

Michael is an infectious disease epidemiologist by training, and has held research positions at Stanford and the University of California, San Francisco.


  • PhD, infectious disease epidemiology, Stanford
  • BS, molecular biology, University of California, San Diego